aXichem AB

Stockholm Stock Exchange AXIC-A.ST

aXichem AB EBIT Margin for the year ending December 31, 2023: -957.32%

aXichem AB EBIT Margin is -957.32% for the year ending December 31, 2023, a -229.55% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

aXichem AB EBIT Margin for the year ending December 31, 2022 was -290.49%, a 15.84% change year over year.
aXichem AB EBIT Margin for the year ending December 31, 2021 was -345.16%, a 68.66% change year over year.
aXichem AB EBIT Margin for the year ending December 31, 2020 was -1,101.30%, a 69.60% change year over year.
aXichem AB EBIT Margin for the year ending December 31, 2019 was -3,623.03%, a -28.94% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

Stockholm Stock Exchange: AXIC-A.ST

aXichem AB

CEO	Mr. Torsten Helsing
IPO Date	March 4, 2011
Location	Sweden
Headquarters	Södergatan 26
Employees	7
Sector	Consumers Staples
Industries Cleaning Supplies Agriculture Composite Materials Meat Organic Foods Personal Care Pet Food Plastics

Description

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, an natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was incorporated in 2007 and is based in Malmö, Sweden.

Key trends

Past 5 years